Serum Vitamin D Status and its Relationship with Metabolic Parameters in Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.3329/mediscope.v9i2.61708Keywords:
25-hydroxycholecalciferol [25(OH) D3], Type 2 diabetes mellitus.Abstract
Vitamin D is a fat-soluble vitamin with hormonal functions, which helps in calcium and phosphate homeostasis and bone metabolism. Beyond the role in bone health, vitamin D influences non-skeletal health problems and chronic diseases like obesity, hypertension, cardiovascular diseases, glucose intolerance and type 2 diabetes mellitus (T2DM). Low vitamin D impairs insulin synthesis and secretion resulting in glucose intolerance in T2DM. This study was carried out between July 2015 to June 2016 to assess vitamin D status in T2DM patients. In this study, vitamin D {25-hydroxycholecalciferol [25(OH)D3]} was assessed in 65 type 2 diabetes mellitus patients and 70 healthy subjects of matching age and sex. Serum 25-hydroxycholecalciferol, fasting blood glucose (FBG), total cholesterol and serum creatinine were estimated. Data were analyzed with the help of the statistical package “R” (version 2.7). Serum 25-hydroxycholecalciferol in cases (Group A) was 55.73±9.02 ng/ml and in controls (Group B) was 53.77±10.86 ng/ml; there was no statistically significant difference between the two groups. Serum FBG was significantly different between the two groups, whereas serum total cholesterol and serum creatinine were not significantly different between the two groups. In type 2 diabetes patients, no significant correlation was found between serum 25-hydroxycholecalciferol with Body mass index (BMI), fasting blood glucose and total cholesterol. In healthy controls, there was no significant correlation of serum 25-hydroxycholecalciferol with BMI, fasting blood glucose and total cholesterol. Vitamin D level was sufficient in both type 2 diabetes patients and healthy individuals. Vitamin D was not associated with T2DM.
Mediscope 2022;9(2): 75-80
Downloads
61
70
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 MT Islam, S Nargis, HL Roy, E Islam, M Sultana, SH Mahmud

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Mediscope agree to the following terms that:
- Authors retain copyright and grant Mediscope the right of first publication of the work.
Articles in Mediscope are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.